Latest Baxter News & Updates

See the latest news and media coverage for Baxter. We track all announcements, press releases, and industry mentions in real time, all in one place.

Baxter

Manufacturer of medical devices, clinical nutrition, and connected-care solutions

baxter.com

Headquarters: Deerfield, United States
Company type: Public company
Number of employees: 35,000+

Last updated Today

Latest news about Baxter

In short: Baxter agreed to sell its kidney care division for $3.8 billion, reported mixed financial results, and appointed an interim CFO to manage debt.

Company announcements

June 22 Baxter

Baxter publishes 2025 Sustainability Report with refreshed strategy

The report includes new net-zero and renewable electricity targets, and a new chief sustainability officer role.

April 30 Baxter

Baxter advances turnaround with GPS system

Teams launched over 230 continuous improvement events in Q1 2026, stabilizing business and strengthening balance sheet.

April 30 Baxter

Baxter reports first-quarter 2026 results

Sales from continuing operations reached $2.7 billion, up 3% reported but down 1% organic. Adjusted EPS was $0.36. Full-year outlook reiterated.

April 2 Baxter

Baxter receives HIRC supply chain awards

Baxter earns Highest Member Choice Award for Supplier Resiliency, Distinguished Member Choice Award for Supplier Transparency, and 2026 Transparency Badge for fourth year. Alan Mavis discusses resiliency.

Media coverage

June 18 GuruFocus

Baxter International Inc (BAX) Stock Down 5.2% -- Now Undervalue

On June 17, 2026, Baxter International Inc (BAX) shares fell 5.2% today, bringing the current price to $19.39. The stock has experienced significant volatility...

June 10 GuruFocus

Why Baxter International Inc (BAX) May Struggle to Outperform: A

Long-established in the Medical Devices & Instruments industry, Baxter International Inc BAX has enjoyed a stellar reputation. Notably, its diminished rankings in financial strength, growth...

June 10 Yahoo Finance

Baxter International (BAX) Faces Tough Road Ahead, Says Citi in Downgrade

With a TTM operating cash flow of $1.25 billion, Baxter International Inc. (NYSE:BAX) is included...

May 31 Pharmaphorum

Baxter slims down again, selling kidney division to Carlyle

Baxter International has agreed to sell its kidney treatment division to private equity firm Carlyle Group in a $3.8 billion cash deal, continuing its efforts...

Never miss news about Baxter

Track Baxter and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.